A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus

被引:33
|
作者
Abed, Yacine
Baz, Mariana
Boivin, Guy [1 ]
机构
[1] CHUQ CHUL, Res Ctr Infect Dis, Ste Foy, PQ G1V 4G2, Canada
来源
JOURNAL OF INFECTIOUS DISEASES | 2009年 / 199卷 / 02期
基金
加拿大健康研究院;
关键词
IMMUNOCOMPROMISED PATIENT; ANTIVIRAL THERAPY; HIGHLY POTENT; IN-VITRO; A VIRUS; INHIBITORS; INFECTIONS;
D O I
10.1086/595736
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neuraminidase (NA) mutations responsible for influenza resistance to oseltamivir vary according to the NA subtype; in influenza A/H3N2 viruses, NA-gene mutations occur predominantly at codons E119 and R292. In an oseltamivir-resistant influenza A/H3N2 virus isolated from an immunocompromised child after 107 days of cumulative treatment, the NA gene contained 3 aa substitutions (N146K, S219T, and A272V) and a 4-aa deletion (Del245-248); reversion mutation experiments using recombinantNAproteins determined that the deletion was the sole change responsible for resistance to oseltamivir. This study highlights the diversity of mechanisms of resistance to oseltamivir in clinical settings, reinforcing the need for novel anti-influenza strategies.
引用
收藏
页码:180 / 183
页数:4
相关论文
共 50 条
  • [31] Combinatorial Effect of Two Framework Mutations (E119V and I222L) in the Neuraminidase Active Site of H3N2 Influenza Virus on Resistance to Oseltamivir
    Richard, Mathilde
    Ferraris, Olivier
    Erny, Alexandra
    Barthelemy, Mendy
    Traversier, Aurelien
    Sabatier, Murielle
    Hay, Alan
    Lin, Yi Pu
    Russell, Rupert J.
    Lina, Bruno
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2942 - 2952
  • [32] Detection of H275Y Mutation Conferring Oseltamivir Drug Resistance in Influenza A (H1N1) pdm09 Virus
    Trivedi, Khushbu
    Malhotra, Bharti
    Dubey, Widhi
    Sharma, Pratibha
    Deeba, Farah
    Tiwari, Jitendra
    Chauhan, Aradhana
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2021, 15 (03): : 1421 - 1428
  • [33] Seroprevalence of a Novel Influenza A (H3N2) Variant Virus in the Japanese Population
    Kishida, Noriko
    Imai, Masaki
    Xu, Hong
    Taya, Keiko
    Fujisaki, Seiichiro
    Takashita, Emi
    Tashiro, Masato
    Odagiri, Takato
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (06) : 549 - 551
  • [34] Variant Influenza A(H3N2) Virus in Indiana
    Kaye, Donald
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (06) : I - I
  • [35] Haemophagocytic syndrome and the influenza virus (H3N2)
    Martin Asenjo, M.
    Martin Guerray, J. M.
    Prieto de Paula, J. M.
    REVISTA CLINICA ESPANOLA, 2020, 220 (03): : 209 - 210
  • [36] Structure of an H3N2 influenza virus nucleoprotein
    Knight, Michael L.
    Fan, Haitian
    Bauer, David L., V
    Grimes, Jonathan M.
    Fodor, Ervin
    Keown, Jeremy R.
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2021, 77 : 208 - 214
  • [37] Cooperating H3N2 Influenza Virus Variants A in Primary Clinical Samples
    Xue, Katherine S.
    Greninger, Alexander L.
    Perez-Osorio, Allyn
    Bloom, Jesse D.
    MSPHERE, 2018, 3 (01)
  • [38] Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses
    Baz, Mariana
    Abed, Yacine
    Simon, Philippe
    Hamelin, Marie-Eve
    Boivin, Guy
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05): : 740 - 745
  • [40] Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice
    Simeonova, Lora
    Gegova, Galina
    Galabov, Angel S.
    ANTIVIRAL RESEARCH, 2012, 95 (02) : 172 - 181